TimesSquare Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-572,353
| Closed | -$23.3M | – | 173 |
|
|
2023
Q2 | $23.3M | Sell |
572,353
-28,730
| -5% | -$1.17M | 0.33% | 116 |
|
|
2023
Q1 | $29.1M | Sell |
601,083
-58,457
| -9% | -$2.83M | 0.43% | 102 |
|
|
2022
Q4 | $25.2M | Sell |
659,540
-72,350
| -10% | -$2.76M | 0.36% | 116 |
|
|
2022
Q3 | $36.7M | Buy |
731,890
+45,990
| +7% | +$2.31M | 0.51% | 94 |
|
|
2022
Q2 | $27.5M | Sell |
685,900
-162,505
| -19% | -$6.51M | 0.38% | 117 |
|
|
2022
Q1 | $31.7M | Sell |
848,405
-234,500
| -22% | -$8.75M | 0.36% | 119 |
|
|
2021
Q4 | $43.1M | Sell |
1,082,905
-46,980
| -4% | -$1.87M | 0.38% | 114 |
|
|
2021
Q3 | $42M | Sell |
1,129,885
-23,900
| -2% | -$889K | 0.37% | 119 |
|
|
2021
Q2 | $48.8M | Buy |
1,153,785
+116,315
| +11% | +$4.92M | 0.4% | 107 |
|
|
2021
Q1 | $49.1M | Sell |
1,037,470
-14,398
| -1% | -$682K | 0.42% | 104 |
|
|
2020
Q4 | $64.2M | Sell |
1,051,868
-109,550
| -9% | -$6.69M | 0.52% | 78 |
|
|
2020
Q3 | $54.3M | Buy |
1,161,418
+165,723
| +17% | +$7.75M | 0.51% | 81 |
|
|
2020
Q2 | $50.5M | Buy |
995,695
+67,320
| +7% | +$3.42M | 0.48% | 89 |
|
|
2020
Q1 | $41.4M | Buy |
928,375
+301,105
| +48% | +$13.4M | 0.49% | 83 |
|
|
2019
Q4 | $30.1M | Buy |
+627,270
| New | +$30.1M | 0.27% | 151 |
|